All Stories

  1. Stratifying IL-2 therapy in ALS: integrating biomarkers

    Article • The Lancet, November 2025, Elsevier

    Yutaka Shimazu

  2. Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures

    Article • Leukemia Research, November 2025, Elsevier

    Yutaka Shimazu

  3. Comparison of stem cell mobilization methods in multiple myeloma

    Article • Cytotherapy, October 2025, Elsevier

    Yutaka Shimazu

  4. Optimizing Allogeneic Chimeric Antigen Receptor T-Cell Persistence in Relapsed/Refractory Large B-Cell Lymphoma: The Role of KIR Matching

    Article • Journal of Clinical Oncology, September 2025, American Society of Clinical Oncology (ASCO)

    Yutaka Shimazu

  5. Exploratory Analysis of Practical Predictive Indices for the Efficacy of Mogamulizumab in Patients With Aggressive Adult T‐Cell Leukemia‐Lymphoma

    Article • Hematological Oncology, June 2025, Wiley

    Yutaka Shimazu

  6. Treatment Intensification Based on Residual Disease in Elderly Patients With AML

    Article • Journal of Clinical Oncology, May 2025, American Society of Clinical Oncology (ASCO)

    Yutaka Shimazu

  7. Glofitamab for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

    Article • Journal of Clinical Oncology, April 2025, American Society of Clinical Oncology (ASCO)

    Yutaka Shimazu

  8. Effect of prevaccination blood and T-cell phenotypes on antibody responses to a COVID-19 mRNA vaccine

    Article • International Immunology, March 2025, Oxford University Press (OUP)

    Yutaka Shimazu

  9. Human Leukocyte Antigen Mismatching and the Role of Killer Cell Immunoglobulin-Like Receptor Mismatch in Hematopoietic Cell Transplantation for Hematologic Malignancies

    Article • Journal of Clinical Oncology, February 2025, American Society of Clinical Oncology (ASCO)

    Yutaka Shimazu

  10. Long‐Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1‐Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of th...

    Article • American Journal of Hematology, February 2025, Wiley

    Yutaka Shimazu

  11. Artificial intelligence-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma

    Article • Annals of Oncology, January 2025, Elsevier

    Yutaka Shimazu

  12. Odronextamab against relapsed or refractory follicular lymphoma

    Article • Annals of Oncology, December 2024, Elsevier

    Yutaka Shimazu

  13. Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome–positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation

    Article • Cancer, November 2024, Wiley

    Yutaka Shimazu

  14. The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients

    Article • Annals of Hematology, August 2024, Springer Science + Business Media

    Yutaka Shimazu

  15. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients

    Article • Medical Oncology, May 2024, Springer Science + Business Media

    Yutaka Shimazu

  16. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation

    Article • Cancer Science, May 2024, Wiley

    Yutaka Shimazu

  17. Acquired Factor V Inhibitor Developed after Radio-chemotherapy for Non-small Cell Lung Carcinoma

    Article • Oncology Advances, March 2024, Xia & He Publishing

    Yutaka Shimazu

  18. Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis

    Article • British Journal of Pharmacology, February 2024, Springer Science + Business Media

    Yutaka Shimazu

  19. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study

    Article • British Journal of Pharmacology, February 2024, Springer Science + Business Media

    Yutaka Shimazu

  20. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study

    Article • December 2023, Springer Science + Business Media

    Yutaka Shimazu

  21. Extramedullary Disease with Bone Marrow Necrosis at Disease Onset in A Case of Mixed Phenotypic Acute Leukemia with BCR::ABL1 Fusion Gene: a Case Report and Review of the Literature

    Article • Oncology Advances, November 2023, Xia & He Publishing

    Yutaka Shimazu

  22. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation

    Article • November 2023, Springer Science + Business Media

    Yutaka Shimazu

  23. Abstract 3 Efficacy of Foscarnet in Preventing HHV6 Encephalitis in Adult Single Cord Blood Transplantation

    Article • Stem Cells Translational Medicine, September 2023, Oxford University Press (OUP)

    Yutaka Shimazu

  24. Prognostic impact of complex karyotype on post‐transplant outcomes of myelofibrosis

    Article • Hematological Oncology, August 2022, Wiley

    Yutaka Shimazu

  25. Double Hit Lymphoma Mimicking B Cell Precursor Phenotype Burkitt Lymphoma/Leukemia in an Elderly

    Article • Journal of Molecular and Clinical Medicine, August 2022, IMR Press

    Yutaka Shimazu

  26. Multiple polypoid lesions with erosion of the gastric mucosa in adult T‐cell lymphoma/leukemia superimposed on cytomegalovirus infection

    Article • eJHaem, June 2022, Wiley

    Yutaka Shimazu

  27. Acute Kidney Injury Possibly Due to the FLT3 Inhibitor Gilteritinib in a Patient with Refractory Acute Myeloid Leukemia: a Case Report

    Article • SN Comprehensive Clinical Medicine, June 2022, Springer Science + Business Media

    Yutaka Shimazu

  28. The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation

    Article • Hematological Oncology, April 2022, Wiley

    Yutaka Shimazu

  29. Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide

    Article • Therapeutic Advances in Hematology, January 2022, SAGE Publications

    Yutaka Shimazu

  30. Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine

    Article • Cancer Science, October 2021, Wiley

    Yutaka Shimazu

  31. P13-6 The effectiveness of mogamulizumab against refractory angioimmunoblastic T cell lymphoma

    Article • Annals of Oncology, July 2021, Elsevier

    Yutaka Shimazu

  32. Vitamin B12 Deficient Megaloblastic Anemia Mimicking Thrombotic Thrombocytopenic Purpura

    Article • SN Comprehensive Clinical Medicine, December 2019, Springer Science + Business Media

    Yutaka Shimazu

  33. Plasma exchange following mogamulizumab therapy before bone marrow transplantation in refractory adult T-cell leukemia–lymphoma

    Article • Leukemia & Lymphoma, May 2019, Taylor & Francis

    Yutaka Shimazu

  34. Non-severe form of severe fever with thrombocytopenia syndrome (SFTS)

    Article • Annals of Hematology, January 2018, Springer Science + Business Media

    Yutaka Shimazu

  35. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations

    Article • Stem Cells, December 2017, Wiley

    Yasuo Miura, Yutaka Shimazu

  36. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, July 2017, Springer Science + Business Media

    Dr Yuho Najima, Yutaka Shimazu

  37. Idiopathic hypereosinophilic syndrome manifesting with eosinophilic cholecystitis and recurrent gastroenteritis

    Article • Annals of Hematology, April 2017, Springer Science + Business Media

    Yutaka Shimazu

  38. Existence ofJAK2mutation 19 years prior to the development of overt polycythemia vera

    Article • Hematological Oncology, March 2017, Wiley

    Yutaka Shimazu

  39. Acute pancreatitis as a side effect of anagrelide hydrochloride hydrate: a case report

    Article • Annals of Hematology, August 2016, Springer Science + Business Media

    Yutaka Shimazu

  40. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia

    Article • Cancer Immunology Research, February 2016, American Association for Cancer Research (AACR)

    Yutaka Shimazu

  41. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis

    Article • Transplant Infectious Disease, January 2013, Wiley

    Yutaka Shimazu

  42. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era

    Article • Cancer Science, November 2011, Wiley

    Yutaka Shimazu

  43. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy

    Article • Molecules and Cells, February 2011, Springer Science + Business Media

    Yutaka Shimazu

  44. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo

    Article • Journal of Experimental Medicine, December 2010, Rockefeller University Press

    Yutaka Shimazu

  45. Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience

    Article • International Journal of Hematology, April 2009, Springer Science + Business Media

    Yutaka Shimazu